Prateek Prasanna
Overview
Explore the profile of Prateek Prasanna including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
1817
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Pati S, Baid U, Edwards B, Sheller M, Wang S, Reina G, et al.
Nat Commun
. 2023 Jan;
14(1):436.
PMID: 36702828
No abstract available.
22.
Pati S, Baid U, Edwards B, Sheller M, Wang S, Reina G, et al.
Nat Commun
. 2022 Dec;
13(1):7346.
PMID: 36470898
Although machine learning (ML) has shown promise across disciplines, out-of-sample generalizability is concerning. This is currently addressed by sharing multi-site data, but such centralization is challenging/infeasible to scale due to...
23.
Alilou M, Khorrami M, Prasanna P, Bera K, Gupta A, Viswanathan V, et al.
Sci Adv
. 2022 Nov;
8(47):eabq4609.
PMID: 36427313
Tumor vasculature is a key component of the tumor microenvironment that can influence tumor behavior and therapeutic resistance. We present a new imaging biomarker, quantitative vessel tortuosity (QVT), and evaluate...
24.
Kobayashi S, Shieh J, Ruiz de Sabando A, Kim J, Liu Y, Zee S, et al.
PLoS One
. 2022 Aug;
17(8):e0268954.
PMID: 36037173
Inflammatory bowel disease (IBD) is a chronic immune-mediated disease of the gastrointestinal tract. While therapies exist, response can be limited within the patient population. Researchers have thus studied mouse models...
25.
Braman N, Prasanna P, Bera K, Alilou M, Khorrami M, Leo P, et al.
Clin Cancer Res
. 2022 Jun;
28(20):4410-4424.
PMID: 35727603
Purpose: The tumor-associated vasculature (TAV) differs from healthy blood vessels by its convolutedness, leakiness, and chaotic architecture, and these attributes facilitate the creation of a treatment-resistant tumor microenvironment. Measurable differences...
26.
Ding R, Prasanna P, Corredor G, Barrera C, Zens P, Lu C, et al.
NPJ Precis Oncol
. 2022 Jun;
6(1):33.
PMID: 35661148
Despite known histological, biological, and clinical differences between lung adenocarcinoma (LUAD) and squamous cell carcinoma (LUSC), relatively little is known about the spatial differences in their corresponding immune contextures. Our...
27.
Ismail M, Prasanna P, Bera K, Statsevych V, Hill V, Singh G, et al.
IEEE Trans Med Imaging
. 2022 Feb;
41(7):1764-1777.
PMID: 35108202
The concept of tumor field effect implies that cancer is a systemic disease with its impact way beyond the visible tumor confines. For instance, in Glioblastoma (GBM), an aggressive brain...
28.
Antunes J, Ismail M, Hossain I, Wang Z, Prasanna P, Madabhushi A, et al.
IEEE J Biomed Health Inform
. 2022 Jan;
26(6):2627-2636.
PMID: 35085099
Localized disease heterogeneity on imaging extracted via radiomics approaches have recently been associated with disease prognosis and treatment response. Traditionally, radiomics analyses leverage texture operators to derive voxel- or region-wise...
29.
Xu X, Samaras D, Prasanna P
Annu Int Conf IEEE Eng Med Biol Soc
. 2021 Dec;
2021:3998-4001.
PMID: 34892107
Intratumor heterogeneity in glioblastoma (GBM) has been linked to adverse clinical outcomes including poor survival and sub-optimal response to therapies. Different techniques, such as radiomics, have been used to characterize...
30.
Bae J, Kapse S, Singh G, Gattu R, Ali S, Shah N, et al.
Diagnostics (Basel)
. 2021 Oct;
11(10).
PMID: 34679510
In this study, we aimed to predict mechanical ventilation requirement and mortality using computational modeling of chest radiographs (CXRs) for coronavirus disease 2019 (COVID-19) patients. This two-center, retrospective study analyzed...